Question explored with the scientific record
Best for thyroid hormone
For most people with overt hypothyroidism, levothyroxine (LT4) alone is the standard first choice, but the evidence shows a meaningful minority do better on a combination that includes the active hormone liothyronine (LT3).
The largest trial in older adults with subclinical hypothyroidism found that levothyroxine did not improve symptoms or tiredness compared to placebo [1][2]. That is a different condition from overt hypothyroidism, but it warns against treating a lab number instead of a person. For overt disease, a 2013 randomized crossover trial found that desiccated thyroid extract (DTE), which contains both T4 and T3, led to modest weight loss (about 3 pounds) and was preferred by nearly half of the 70 participants, even though it did not significantly improve overall quality-of-life scores [4]. A 2025 case series reported that adding LT3 to reduced LT4 raised total T3 levels and resolved fatigue in three patients who had persistent symptoms despite normal TSH on LT4 alone [3]. A 2025 review notes that while meta-analyses show no consistent population-level benefit for combination therapy, some patients report better satisfaction, and LT3 may have a more favorable effect on weight and lipids [5].
The key limitation: the evidence for combination therapy comes from small studies and case series, not large long-term trials. The standard starting dose for LT4 is about 1.6 mcg per kilogram of body weight per day, adjusted by TSH [6][7]. If you have persistent fatigue, brain fog, or weight gain despite a normal TSH on LT4 alone, a trial of LT4/LT3 combination or DTE is a reasonable option to discuss with a clinician who is open to it. The evidence does not support it for everyone, but it does support it for some.
My call: levothyroxine is the proven first-line therapy, but combination therapy with LT3 or desiccated thyroid is a legitimate option for people with persistent symptoms, supported by patient preference data and mechanistic plausibility. Confidence: moderate.
Sources used 7
-
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
This study investigates the clinical benefits of levothyroxine treatment in older adults with subclinical hypothyroidism, finding no significant improvements in thyroid-related symptoms or quality of life compared to placebo.
DOI: 10.1056/NEJMoa1603825 -
In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness
In older adults with subclinical hypothyroidism, a randomized placebo-controlled trial found that levothyroxine did not improve symptoms or tiredness compared to placebo.
DOI: 10.7326/ACPJC-2017-167-4-014 -
SAT-409 Evaluating the Role of Liothyronine and Levothyroxine Combination Therapy in Persistent Hypothyroidism Symptoms: A Case Series
This case series reports that adding liothyronine to reduced levothyroxine improved symptoms and raised total T3 in three hypothyroid patients who had persistent symptoms and low T3 despite normal TSH.
DOI: 10.1210/jendso/bvaf149.2322 -
Desiccated Thyroid Extract Compared With Levothyroxine in the Treatment of Hypothyroidism: A Randomized, Double-Blind, Crossover Study
This study investigates the effectiveness of desiccated thyroid extract (DTE) compared to levothyroxine (L-T4) in treating hypothyroidism, finding that while DTE did not significantly improve quality of life, it resulted in modest weight loss and a preference for DTE among nearl…
DOI: 10.1210/jc.2012-4107 -
Liothyronine Therapy in Hypothyroidism
This narrative review finds that levothyroxine remains standard therapy for hypothyroidism, while liothyronine or LT4/LT3 combination therapy lacks consistent trial benefit but may be considered in selected patients with persistent symptoms, metabolic comorbidities, or specific …
DOI: 10.56260/sciena.v4i5.277 -
Development and Prospective Validation of the Levothyroxine Dose Prediction Model in Primary Hypothyroidism
A levothyroxine dose prediction model based on pretreatment TSH and gender, developed in a prospective training cohort and validated in a separate prospective cohort, showed excellent concordance with final doses and achieved euthyroidism at first follow-up in 68% of validation …
DOI: 10.1055/a-1336-3502 -
Weight-based Levothyroxine Dose Calculator for Hypothyroidism in Adults
A 1.6 mcg/kg/day weight-based levothyroxine starting-dose calculator is evidence-based for non-pregnant adults under 65 with primary hypothyroidism and minimal residual function, with cautions for obesity, age, and cardiac disease.
DOI: 10.65357/001c.145848